Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action inhibitors |
Mechanism WEE1 inhibitors(Serine/threonine-protein kinase WEE1 inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC42H45N11O6 |
InChIKeyLZUDSNUROXNVPH-UHFFFAOYSA-N |
CAS Registry2414418-49-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | United States | 01 Jan 2020 |